StonvexLoading…
StonvexStonvexStonvexCore line items from SVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $361.37M | $470.17M | $1.47B | $19.37B |
Operating Income | $-505.54M | $-713.98M | $-508.99M | $17.62B |
Net Income | $40.66M | $-13.49M | $14.47M | $8.12B |
EPS (Diluted) | $1.27 | $-0.19 | $0.20 | $113.44 |
Total Assets | $12.34B | $13.61B | $14.03B | $16.76B |
Total Liabilities | $2.04B | $1.97B | $1.79B | $3.21B |
Cash & Equivalents | $335.27M | $1.12B | $3.88B | $11.61B |
Free Cash Flow OCF − CapEx | $-152.85M | $-17.52M | $-1.11B | $14.73B |
Shares Outstanding | 71.86M | 71.86M | 71.72M | 71.72M |